These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 4285526)

  • 1. Intratypic serodifferentiation of oral poliovaccine progeny.
    Ozaki Y; Takizawa M
    Acta Sch Med Univ Kioto; 1965 Jun; 39(2):81-91. PubMed ID: 4285526
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiological implications of the isolations and intratypic serodifferentiation of poliovirus strains in the Netherlands.
    Kapsenberg JG; Coutinho RA; Hazendonk AG; Ran AB; van Wezel AL
    Dev Biol Stand; 1981; 47():293-301. PubMed ID: 6262154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characterization and purity testing of a complement-fixing N-D-polioviri on-type I-antigen for routine diagnosis and intratypic serodifferentiation].
    Höher PG; Böhme U; Kuwert E; Lickfeld KG
    Zentralbl Bakteriol Orig A; 1972 Oct; 222(1):1-17. PubMed ID: 4145148
    [No Abstract]   [Full Text] [Related]  

  • 4. Intratypic serodifferentiation of poliovirus type 1 isolates using kinetic neutralization test.
    Deshpande JM; Dave KH
    Indian J Med Res; 1987 Oct; 86():419-22. PubMed ID: 2832324
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
    Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
    Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serodifferentiation of type 3 poliovirus strains isolated 1960-1965 from patients and healthy vaccinees. Characterization of strains associated with disease in vaccinated persons and household contacts.
    Deibel R; Macdonald D
    Am J Epidemiol; 1968 Mar; 87(2):396-410. PubMed ID: 4296727
    [No Abstract]   [Full Text] [Related]  

  • 7. Intratypic serodifferentiation of polioviruses by comparison of neutralization indices and correlation of the antigenic marker, temperature marker and monkey neurovirulence.
    Smit GL; Wilterdink JB
    Arch Gesamte Virusforsch; 1966; 18(3):261-75. PubMed ID: 4295526
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigenic characterization of oral poliovaccine progeny by neutralization kinetics.
    OZAKI Y; DIWAN AR; McBRIDE WD; MELNICK JL
    J Immunol; 1963 Feb; 90():288-96. PubMed ID: 13940879
    [No Abstract]   [Full Text] [Related]  

  • 9. Intratypic serodifferentiation of poliomyelitis virus strains by strain-specific antisera.
    van Wezel AL; Hazendonk AG
    Intervirology; 1979; 11(1):2-8. PubMed ID: 218891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intratypic serological identification of poliovirus by the method of comparison of neutralization indices].
    Stewien KE
    Rev Saude Publica; 1971 Dec; 5(2):243-61. PubMed ID: 4333622
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intratypic serodifferentiation of poliovirus by immunodiffusion test (author's transl)].
    Sorrentino V; Giorgi C
    Ann Ist Super Sanita; 1981; 17(2):231-9. PubMed ID: 6277222
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intratypic differentiation of poliovirus strains isolated from sewage: consequences for the practise of oral vaccination].
    Kuwert E; Höher PG; Primavesi CA
    Zentralbl Bakteriol Orig; 1970; 215(1):16-25. PubMed ID: 4321148
    [No Abstract]   [Full Text] [Related]  

  • 13. Problems with oral poliovaccine in India.
    John TJ
    Indian Pediatr; 1972 May; 9(5):252-6. PubMed ID: 4649422
    [No Abstract]   [Full Text] [Related]  

  • 14. Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine.
    Ogra PL; Karzon DT
    J Immunol; 1969 Jun; 102(6):1423-30. PubMed ID: 4977607
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new intratypic serodifferentiation technic for use with strains of poliomyelitis virus, type 3].
    Trimoreau JC; Maurin J
    Ann Inst Pasteur (Paris); 1967 Feb; 112(2):130-6. PubMed ID: 4291715
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
    Shyrobokov VP; Nikolaienko IV; Kopanytsia LV; Solohub VK; Ivanova OIe
    Mikrobiol Z; 1997; 59(6):27-36. PubMed ID: 9511373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic characterization of poliovirus isolates in Canada, 1962-1981.
    Furesz J; Armstrong RE; Contreras G; Wachmann B
    Rev Infect Dis; 1984; 6 Suppl 2():S528-34. PubMed ID: 6330852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine.
    Vonka V; Janda Z; Simon J; Adam E; Stárek M
    Prog Med Virol; 1967; 9():204-55. PubMed ID: 4293687
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of cross-absorbed sera in neutralization tests with viral titration by the cytopathogenic effect].
    Pervikov IuV; Chumakov MP; Voroshilova MK; Rubin SG
    Vopr Virusol; 1975; (3):309-12. PubMed ID: 169628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.